Kiraz S - Search Results

1

Is Takayasu's arteritis more severe in children?

Bolek EC, Kaya Akca U, Sari A, Sag E, Demir S, Kilic L, Sener YZ, Aykan HH, Kaya EB, Bilginer Y, Akdogan A, Kiraz S, Karadag O, Ozen S. Bolek EC, et al. Among authors: kiraz s. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):32-38. doi: 10.55563/clinexprheumatol/kr357t. Epub 2020 Sep 16. Clin Exp Rheumatol. 2021. PMID: 32940211 Free article.

2

Parvovirus B19 infection in Behçet's disease.

Kiraz S, Ertenli I, Benekli M, Calgüneri M. Kiraz S, et al. Clin Exp Rheumatol. 1996 Jan-Feb;14(1):71-3. Clin Exp Rheumatol. 1996. PMID: 8697661

3

Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.

Calgüneri M, Pay S, Calişkaner Z, Apraş S, Kiraz S, Ertenli I, Cobankara V. Calgüneri M, et al. Among authors: kiraz s. Clin Exp Rheumatol. 1999 Nov-Dec;17(6):699-704. Clin Exp Rheumatol. 1999. PMID: 10609068 Clinical Trial.

4

Interactions of nitric oxide and superoxide dismutase in Behçet's disease.

Kiraz S, Ertenli I, Calgüneri M, Oztürk MA, Haznedaroglu IC, Altun B, Erman M, Celik I. Kiraz S, et al. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S25-9. Clin Exp Rheumatol. 2001. PMID: 11760394

5

Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus.

Calgüneri M, Oztürk MA, Ozbalkan Z, Akdogan A, Ureten K, Kiraz S, Ertenli I. Calgüneri M, et al. Among authors: kiraz s. J Int Med Res. 2003 Jul-Aug;31(4):345-9. doi: 10.1177/147323000303100415. J Int Med Res. 2003. PMID: 12964513 Free article.

6

The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort study.

Ozbalkan Z, Topeli A, Kiraz S, Ozturk MA, Ertenli I, Calguneri M. Ozbalkan Z, et al. Among authors: kiraz s. Clin Exp Rheumatol. 2004 Mar-Apr;22(2):223-6. Clin Exp Rheumatol. 2004. PMID: 15083891

7

Takayasu's arteritis: results of a university hospital of 45 patients in Turkey.

Ureten K, Oztürk MA, Onat AM, Oztürk MH, Ozbalkan Z, Güvener M, Kiraz S, Ertenli I, Calgüneri M. Ureten K, et al. Among authors: kiraz s. Int J Cardiol. 2004 Aug;96(2):259-64. doi: 10.1016/j.ijcard.2003.07.017. Int J Cardiol. 2004. PMID: 15262043

8

The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.

Calguneri M, Apras S, Ozbalkan Z, Ozturk MA, Ertenli I, Kiraz S. Calguneri M, et al. Among authors: kiraz s. Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):S41-4. Clin Exp Rheumatol. 2004. PMID: 15515783

9

Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.

Calgüneri M, Onat AM, Oztürk MA, Ozçakar L, Ureten K, Akdogan A, Ertenli I, Kiraz S. Calgüneri M, et al. Among authors: kiraz s. Clin Rheumatol. 2005 Feb;24(1):64-6. doi: 10.1007/s10067-004-0944-1. Epub 2004 Oct 26. Clin Rheumatol. 2005. PMID: 15517447

10

Neutrophil CD64 expression in Behçet's disease.

Ureten K, Ertenli I, Oztürk MA, Kiraz S, Onat AM, Tuncer M, Okur H, Akdogan A, Apras S, Calgüneri M. Ureten K, et al. Among authors: kiraz s. J Rheumatol. 2005 May;32(5):849-52. J Rheumatol. 2005. PMID: 15868620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters